Alphamab Oncology Announces Biparatopic HER2-targeting ADC JSKN003 Was Granted Breakthrough Therapy Designation by the FDA for the Treatment of PROC
SUZHOU, China, Dec. 20, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003, independently developed by the Company, and co-developed with JMT-Bio...
Nobu Manchester breaks ground as Robert De Niro visits Manchester with Salboy
MANCHESTER, England, Dec. 20, 2025 /PRNewswire/ -- Robert De Niro visited Manchester with fellow Nobu Hospitality founders Chef Nobu Matsuhisa and Meir Teper, joining Salboy on site to mark the Nobu Manchester groundbreaking and the next stage of...
SamSan SLC Launches 'OXCUS,' a PFAS-Free Industrial Solid Lubricant Coating Brand
SEOUL, South Korea, Dec. 16, 2025 /PRNewswire/ -- SamSan SLC, a solid lubricant coating manufacturer in Korea with a long-standing history in eco-friendly material science, announced the official launch of its new PFAS-free dry film lubricant brand,...
Breakthrough Progress: METiS TechBio Publishes Consecutive Research Findings in Nature Communications and the Journal for ImmunoTherapy of Cancer
BEIJING, Dec. 16, 2025 /PRNewswire/ -- METiS TechBio ("METiS") today announced that two of its oncology pipeline candidates, MTS-105 and MTS-107, have been published in leading international peer-reviewed journals, Nature Communications and the...
Perennial Healthcare City Launched Adjacent to Chongqing East HSR Station, Western China's Largest HSR Hub
Establishment of new healthcare gateway in Chongqing amid the 10th anniversary of the Chongqing Connectivity Initiative and as part of the 35th anniversary celebration of Singapore-China diplomatic relations; Maiden investment in Chongqing marks...
Miroma Project Factory: Powers Clinical-Grade App for One of Australia's Largest Smoking Cessation Trials
SYDNEY, Dec. 16, 2025 /PRNewswire/ -- Miroma Project Factory (MPF) has delivered a bespoke mobile solution for Screen2Quit, part of the International Lung Study trial and one of Australia's most ambitious research studies targeting smoking cessation...
Ping An Wins ESG Excellence at Hong Kong Corporate Governance & ESG Excellence Awards 2025
HONG KONG and SHANGHAI, Dec. 15, 2025 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("Ping An" or "the Group", HKEX: 2318/82318; SSE: 601318) has been honored with the Award of Excellence in ESG in the category of Hang Seng Index...
Solidion Technology develops a new high-capacity, low-cost anode
Recently discovered anode is composed of low-cost silicon particles protected by a flexible rubber to significantly extend the range of commercial drones DALLAS, Dec. 15, 2025 /PRNewswire/ -- Solidion Technology, Inc. (Nasdaq: STI), an advanced...
Ascletis Announces Positive Topline Results from U.S. Phase I Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor
- The elimination half-life of ASC50 after a single oral dose was 43, 89, 91, 87, 104, and 85 hours for 10 mg, 30 mg, 100 mg, 200 mg, 400 mg, and 600 mg, respectively, supporting once - daily or potentially once-weekly oral dosing. - ASC50 had...
DWMaterials: "Building Trust Through Precise Physical Analysis"
SEOUL, South Korea, Dec. 12, 2025 /PRNewswire/ -- DWMaterials announced that it has successfully developed a stable heat-generation control technology. This advancement enables the company to resolve issues such as reduced magnetic field separation...